Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-11-08
2005-11-08
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S314000, C514S235200
Reexamination Certificate
active
06962928
ABSTRACT:
The current invention provides methods for inhibiting osteoporosis, estrogen dependent breast cancer, endometriosis and uterine fibrosis comprising administering to a patient in need thereof a compound of the formula:
REFERENCES:
patent: 3819637 (1974-06-01), Bell
patent: 3994902 (1976-11-01), Bell
patent: 4075227 (1978-02-01), Jones et al.
patent: 4133814 (1979-01-01), Jones et al.
patent: 4230862 (1980-10-01), Suarez et al.
patent: 4418068 (1983-11-01), Jones
patent: 5393763 (1995-02-01), Black et al.
patent: 5403847 (1995-04-01), Gluchowski et al.
patent: 5446053 (1995-08-01), Keohane
patent: 5457116 (1995-10-01), Black et al.
patent: 5461065 (1995-10-01), Black et al.
patent: 5482949 (1996-01-01), Black et al.
patent: 5508306 (1996-04-01), Chiu et al.
patent: 5510357 (1996-04-01), Palkowitz
patent: 5523309 (1996-06-01), Bryant et al.
patent: 5567828 (1996-10-01), Dodge
patent: 5686465 (1997-11-01), Yves et al.
patent: 5688796 (1997-11-01), Cullinan et al.
patent: 5693345 (1997-12-01), Chen et al.
patent: 5723474 (1998-03-01), Palkowitz
patent: 5726168 (1998-03-01), Cullinan et al.
patent: 5728724 (1998-03-01), Bryant et al.
patent: 5811421 (1998-09-01), Dodge et al.
patent: 5840735 (1998-11-01), Labrie et al.
patent: 5843963 (1998-12-01), Hauser et al.
patent: 5843965 (1998-12-01), Palkowitz
patent: 5916916 (1999-06-01), Hauser et al.
patent: 5929090 (1999-07-01), Hauser et al.
patent: 5948795 (1999-09-01), Berg et al.
patent: 5948796 (1999-09-01), Bryant et al.
patent: 5958916 (1999-09-01), Bryant et al.
patent: 5958969 (1999-09-01), Bryant et al.
patent: 5962475 (1999-10-01), Schmid et al.
patent: 5981570 (1999-11-01), Bryant et al.
patent: 5985897 (1999-11-01), Muehl et al.
patent: 5998401 (1999-12-01), Palkowitz
patent: 5998442 (1999-12-01), Yong Cho et al.
patent: 6017914 (2000-01-01), Bryant et al.
patent: 6025382 (2000-02-01), Bastian et al.
patent: 6060488 (2000-05-01), Dodge et al.
patent: 6090843 (2000-07-01), Bryant et al.
patent: 6303634 (2001-10-01), Cohen et al.
patent: 6384053 (2002-05-01), Muehl
patent: 6391892 (2002-05-01), Bryant et al.
patent: 6395755 (2002-05-01), Bryant et al.
patent: 6399634 (2002-06-01), Bryant et al.
patent: 6410564 (2002-06-01), Bryant et al.
patent: 6417199 (2002-07-01), Muehl
patent: 6432982 (2002-08-01), Cullinan et al.
patent: 6432983 (2002-08-01), Cullinan et al.
patent: 6440958 (2002-08-01), Jones et al.
patent: 6444688 (2002-09-01), Dodge et al.
patent: 6479517 (2002-11-01), Bryant et al.
patent: 6509356 (2003-01-01), Dodge et al.
patent: 6599920 (2003-07-01), Bryant et al.
patent: 6608090 (2003-08-01), Bourgeois et al.
patent: 0 773 217 (1997-05-01), None
patent: 0 802 183 (1997-10-01), None
patent: 0 802 184 (1997-10-01), None
patent: 0 747 380 (1998-09-01), None
patent: 0 729 951 (1999-06-01), None
patent: 1 113 007 (2001-07-01), None
patent: 04 316557 (1992-11-01), None
patent: WO 95/10513 (1995-04-01), None
patent: WO 95/17382 (1995-06-01), None
patent: WO 96/32937 (1996-10-01), None
patent: WO 97/25033 (1997-07-01), None
patent: WO 98 08797 (1998-03-01), None
patent: 0 835 867 (1998-04-01), None
patent: WO 98/48793 (1998-11-01), None
patent: WO 99/19293 (1999-04-01), None
patent: WO 99/59969 (1999-11-01), None
XP002170868; “Structure-Activity-Relationship of Antiestrogens. Effect of the Side Chain and Its Position on the Activity of 2,3-Diaryl-2H-1-Benzopyrans”; Sharma, A.P., et al; Journal of Medicinal Chemistry, American Chemical Society, Washington, U.S.; vol. 33; 1990; pp. 3216-3222.
Boudreaux William R.
Eli Lilly and Company
Spivack Phyllis G.
Voy Gilbert T.
LandOfFree
Tetrahydroquinoline derivatives for the inhibition of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydroquinoline derivatives for the inhibition of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydroquinoline derivatives for the inhibition of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3468866